Executive Summary of the Focused Update of the ASAM National Practice Guideline for the Treatment of Opioid Use Disorder

Executive Summary of the Focused Update of the ASAM National Practice Guideline for the Treatment of Opioid Use Disorder
复制标题

DOI:
10.1097/adm.0000000000000635
复制
发表时间:
2020-03-01
影响因子:
5.5
通讯作者:
Kampman, Kyle M.
Kampman, Kyle M.
中科院分区:
医学3区
文献类型:
--
作者:
Crotty, Karen;Freedman, Kenneth I.;Kampman, Kyle M.

文献摘要

被引文献

相似文献

ASAM阿片类药物使用障碍治疗国家实践指南的重点更新发表在最新一期的成瘾医学杂志上。重点更新包括检索2014年1月1日至2018年9月27日的Medline PubMed数据库,以及检索灰色文献(临床指南交换所档案,以及主要机构和社会网站),以获得新的实践指南和相关系统性综述,这些指南和综述涉及阿片类药物使用障碍治疗中药物和心理社会治疗的使用,包括特殊人群。检索确定了13个实践指南和35个系统评价,为随后的兰德/加州大学洛杉矶分校适当方法(RAM)过程提供了信息,以促进成瘾专家的国家指南委员会的重点更新。纳入新的和更新的建议,如果它们被认为:(a)具有临床意义并适用于治疗阿片类药物使用成瘾的广泛临床医生;(B)迫切需要确保实践指南反映现有建议的科学现状,与其他相关实践指南保持一致,并反映新批准的药物和制剂。
A Focused Update of the ASAM National Practice Guideline for the Treatment of Opioid Use Disorder is published in the current issue of the Journal of Addiction Medicine. The focused update included a search of Medline's PubMed database from January 1, 2014 to September 27, 2018, as well as a search of the grey literature (archives of the Clinical Guideline Clearinghouse, and key agency and society websites) for new practice guidelines and relevant systematic reviews addressing the use of medications and psychosocial treatments in the treatment of opioid use disorder, including within special populations. The search identified 13 practice guidelines and 35 systematic reviews that informed the subsequent RAND/UCLA Appropriateness Method (RAM) process employed to facilitate the focused update by a National Guideline Committee of addiction experts. New and updated recommendations were included if they were considered: (a) clinically meaningful and applicable to a broad range of clinicians treating addiction involving opioid use; and (b) urgently needed to ensure the Practice Guideline reflects the current state of the science for the existing recommendations, aligns with other relevant practice guidelines, and reflects newly approved medications and formulations.